![]() |
![]() |
|
|
Forward to a colleague |
||
Access Full Stories Like countless pets after every Christmas, it seems that nobody wanted Biogen Idec after all; the firm has announced it will remain independent after it 'did not receive any definitive offers to purchase the company'... Read Merck confirms diabetes retreat Merck Serono intends to forge ahead with severing its investment in diabetes and either sell or partner out its existing research and development (R&D) activities in this field, which it no longer feels able... Read New cell line to tackle drug resistant cancer The creation of a new 'super cell' that can stand firm against one of the newest types of cancer therapy could shed new light on how to treat patients if they become resistant to these drugs... Read BioWa and Lonza agreement for potent antibodies BioWa and Lonza are joining forces to develop a new technology platform to produce more potent antibodies with enhanced cell-killing powers... Read Mini synchrotron to ease structural analysis? Researchers have developed a miniature synchrotron that could enable researchers to conduct protein crystallography experiments in their own university and 'revolutionise the way science is done'... Read |
|||||||||||||||||
All News Headlines for: December | November | October |
|||||||||||||||||
ZIC®-HILIC Separation of Polar and Hydrophilic Compounds The technology leading ZIC®HILIC and ZIC®-pHILIC separation media, designed for polar and hydrophilic compounds, are tools for clinical analysis and to solve separation and purification problems in research, development and production of pharmaceuticals. ZIC®-HILIC... Click Here | |||||||||||||||||
|
Related Industry News Biomarker detection gets 'sticky' US researchers have developed a fast and inexpensive protein biomarker detection device that could simplify disease diagnosis and aid in following disease progression in drug trials... Read Pharmaceutical patent round-up In-PharmaTechnologist.com brings you an update of pharmaceutical patent litigations... Read NNE wins Pronova contract NNE Pharmaplan has won a contract with Pronova BioPharma to build the company's new pharma production facility in Kalundborg, Denmark... Read Invitrogen 'clicks' with Harvard for assay tech Invitrogen has exclusively licensed 'click chemistry' technology from Harvard University that greatly simplifies the fluorescent-labelling of biomolecules for use in proliferation assays... Read
|
|||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||